Moderna Hantavirus Efforts Underway Before Cruise Ship Outbreak
Moderna’s early hantavirus research drew investor attention as no approved vaccine exists and the project is expected to take years, researchers said.
6 Articles
6 Articles
Moderna flags work on hantavirus vaccines before cruise outbreak - The Boston Globe
“These efforts are early-stage and ongoing and reflect Moderna’s broader responsibility to develop countermeasures against emerging infectious diseases,” the Cambridge-based company said.
Moderna Works on Hantavirus: Reports Claim the Biotech Giant Has Started Early-Stage Research of the Jab
Moderna, the US biotech company best known for its COVID‑19 vaccine, has reportedly begun early research into a vaccine for hantavirus. The announcement, which drove the company's share price up significantly, has raised questions about what this vaccine might mean for public health and how soon it might be available. The Boston Globe reported that investors reacted strongly when word circulated that Moderna is working on a hantavirus jab, under…
Mexico City, Mexico.- The U.S. pharmaceutical company Moderna announced this Friday that it is already working on preliminary investigations to develop a vaccine against hantavirus, amid the international concern generated by the outbreak detected on the cruise ship MV Hondius, where so far at least three deaths have been reported.The announcement immediately boosted the company’s actions on Wall Street, where its titles recorded an increase of …
Moderna has conducted preliminary research on Hantavirus vaccines in collaboration with USAMRIID
Coverage Details
Bias Distribution
- 75% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
